Is 0.01% Atropine an Effective and Safe Treatment for Myopic Children? A Systemic Review and Meta-Analysis
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Is 0.01% Atropine an Effective and Safe Treatment for Myopic Children? A Systemic Review and Meta-Analysis
Authors
Keywords
-
Journal
Journal of Clinical Medicine
Volume 10, Issue 17, Pages 3766
Publisher
MDPI AG
Online
2021-08-24
DOI
10.3390/jcm10173766
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Efficacy and safety of 0.01% atropine for prevention of childhood myopia in a 2-year randomized placebo-controlled study
- (2021) Osamu Hieda et al. JAPANESE JOURNAL OF OPHTHALMOLOGY
- Side effects of topical atropine 0.05% compared to 0.01% for myopia control in German school children: a pilot study
- (2021) Lutz Joachimsen et al. INTERNATIONAL OPHTHALMOLOGY
- The Effect of Long-Term Low-Dose Atropine on Refractive Progression in Myopic Australian School Children
- (2021) William Myles et al. Journal of Clinical Medicine
- Effect of low-dose atropine on myopia progression, pupil diameter and accommodative amplitude: low-dose atropine and myopia progression
- (2020) Aicun Fu et al. BRITISH JOURNAL OF OPHTHALMOLOGY
- Review: Myopia control strategies recommendations from the 2018 WHO/IAPB/BHVI Meeting on Myopia
- (2020) Marcus Ang et al. BRITISH JOURNAL OF OPHTHALMOLOGY
- Differential Effects on Ocular Biometrics by 0.05%, 0.025%, and 0.01% Atropine
- (2020) Fen Fen Li et al. OPHTHALMOLOGY
- Safety and Efficacy of Low-Dose Atropine Eyedrops for the Treatment of Myopia Progression in Chinese Children
- (2020) Shifei Wei et al. JAMA Ophthalmology
- Efficacy and safety of atropine to control myopia progression: a systematic review and meta-analysis
- (2020) Congling Zhao et al. BMC Ophthalmology
- Efficacy of atropine 0.01% for the treatment of childhood myopia in European patients
- (2019) Matteo Sacchi et al. ACTA OPHTHALMOLOGICA
- Which low‐dose atropine for myopia control?
- (2019) Safal Khanal et al. Clinical and Experimental Optometry
- Atropine 0.01% eye drops slow myopia progression: a systematic review and Meta-analysis
- (2019) Ying Zhao International Journal of Ophthalmology
- RoB 2: a revised tool for assessing risk of bias in randomised trials
- (2019) Jonathan A C Sterne et al. BMJ-British Medical Journal
- Two-Year Clinical Trial of the Low-Concentration Atropine for Myopia Progression (LAMP) Study
- (2019) Jason C. Yam et al. OPHTHALMOLOGY
- Low-Concentration Atropine for Myopia Progression (LAMP) Study
- (2018) Jason C. Yam et al. OPHTHALMOLOGY
- Methods to calculate uncertainty in the estimated overall effect size from a random-effects meta-analysis
- (2018) Areti Angeliki Veroniki et al. Research Synthesis Methods
- The Lowdown on Low-Concentration Atropine for Myopia Progression
- (2018) Padmaja Sankaridurg et al. OPHTHALMOLOGY
- Efficacy and Adverse Effects of Atropine in Childhood Myopia
- (2017) Qianwen Gong et al. JAMA Ophthalmology
- The acceptability and visual impact of 0.01% atropine in a Caucasian population
- (2016) James Loughman et al. BRITISH JOURNAL OF OPHTHALMOLOGY
- Effectiveness study of atropine for progressive myopia in Europeans
- (2016) J R Polling et al. EYE
- Five-Year Clinical Trial on Atropine for the Treatment of Myopia 2
- (2016) Audrey Chia et al. OPHTHALMOLOGY
- Efficacy Comparison of 16 Interventions for Myopia Control in Children
- (2016) Jinhai Huang et al. OPHTHALMOLOGY
- Global Prevalence of Myopia and High Myopia and Temporal Trends from 2000 through 2050
- (2016) Brien A. Holden et al. OPHTHALMOLOGY
- ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions
- (2016) Jonathan AC Sterne et al. BMJ-British Medical Journal
- ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions
- (2016) Jonathan AC Sterne et al. BMJ-British Medical Journal
- Association of Axial Length With Risk of Uncorrectable Visual Impairment for Europeans With Myopia
- (2016) J. Willem L. Tideman et al. JAMA Ophthalmology
- Therapeutic effect of atropine 1% in children with low myopia
- (2015) Shu Yi et al. JOURNAL OF AAPOS
- Atropine 0.01% Eyedrops Significantly Reduce the Progression of Childhood Myopia
- (2015) Tiana Y. Clark et al. JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS
- The myopia boom
- (2015) Elie Dolgin NATURE
- Random-effects meta-analysis: the number of studies matters
- (2015) Annamaria Guolo et al. STATISTICAL METHODS IN MEDICAL RESEARCH
- Prevalence and Associated Factors of Myopia in High-School Students in Beijing
- (2015) Li Juan Wu et al. PLoS One
- Atropine Slows Myopia Progression More in Asian Than White Children by Meta-analysis
- (2014) Shi-Ming Li et al. OPTOMETRY AND VISION SCIENCE
- Maximum Atropine Dose Without Clinical Signs or Symptoms
- (2013) Jeffrey Cooper et al. OPTOMETRY AND VISION SCIENCE
- Refractive Error, Visual Acuity and Causes of Vision Loss in Children in Shandong, China. The Shandong Children Eye Study
- (2013) Jian Feng Wu et al. PLoS One
- Global cost of correcting vision impairment from uncorrected refractive error
- (2012) TR Fricke et al. BULLETIN OF THE WORLD HEALTH ORGANIZATION
- Topographic Analyses of Shape of Eyes with Pathologic Myopia by High-Resolution Three-Dimensional Magnetic Resonance Imaging
- (2011) Muka Moriyama et al. OPHTHALMOLOGY
- Atropine for the Treatment of Childhood Myopia: Safety and Efficacy of 0.5%, 0.1%, and 0.01% Doses (Atropine for the Treatment of Myopia 2)
- (2011) Audrey Chia et al. OPHTHALMOLOGY
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started